Yuesong Pan Selected Research

Clopidogrel (Plavix)

11/2022	No rebound effect after a course of clopidogrel in patients with acute TIA or minor stroke.
10/2022	Predictive values of baseline matrix metalloproteinase 9 levels in peripheral blood on 3-month outcomes of high-risk patients with minor stroke or transient ischemic attack.
8/2022	Coexistent cerebral small vessel disease and multiple infarctions predict recurrent stroke.
1/2022	Application of Age, Body Mass Index, Chronic Kidney Disease, Diabetes, and Genotyping Score for Efficacy of Clopidogrel: Secondary Analysis of the CHANCE Trial.
1/2022	Time Course for Benefit and Risk With Ticagrelor and Aspirin in Individuals With Acute Ischemic Stroke or Transient Ischemic Attack Who Carry CYP2C19 Loss-of-Function Alleles: A Secondary Analysis of the CHANCE-2 Randomized Clinical Trial.
12/2021	Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA.
1/2021	Clopidogrel with aspirin in High-risk patients with Acute Non-disabling Cerebrovascular Events II (CHANCE-2): rationale and design of a multicentre randomised trial.
1/2021	Comparison of outcome of patients with acute minor ischaemic stroke treated with intravenous t-PA, DAPT or aspirin.
1/2021	F2R Polymorphisms and Clopidogrel Efficacy and Safety in Patients With Minor Stroke or TIA.
12/2020	Antiplatelet effect of ticagrelor with aspirin in acute minor stroke and transient ischemic attack stratified by CYP2C19 metabolizer status: subgroup analysis of the PRINCE trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuesong Pan Research Topics

Disease

111	Stroke (Strokes) 11/2022 - 01/2013
93	Ischemic Stroke 11/2022 - 01/2014
38	Transient Ischemic Attack 11/2022 - 06/2014
16	Hemorrhage 01/2022 - 07/2015
11	Diabetes Mellitus 12/2021 - 08/2013
10	Insulin Resistance 01/2022 - 01/2017
8	Prediabetic State (Prediabetes) 08/2022 - 09/2014
7	Atrial Fibrillation 01/2022 - 05/2013
7	Pathologic Constriction (Stenosis) 01/2021 - 01/2013
5	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 01/2017
5	Cognitive Dysfunction 02/2022 - 01/2021
5	Chronic Renal Insufficiency 01/2022 - 01/2018
5	Atherosclerosis 01/2022 - 08/2018
5	Hyperglycemia 01/2020 - 11/2017
5	Cerebral Hemorrhage 01/2019 - 10/2015
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021 - 03/2015
4	Type 2 Diabetes Mellitus (MODY) 11/2020 - 01/2018
3	Cerebral Small Vessel Diseases 11/2022 - 01/2014
3	Inflammation (Inflammations) 11/2022 - 01/2019
3	Hypertension (High Blood Pressure) 01/2022 - 01/2019
3	Infarction (Infarctions) 01/2021 - 01/2018
2	Pain (Aches) 01/2021 - 01/2018
2	Alzheimer Disease (Alzheimer's Disease) 11/2020 - 12/2019
2	Thrombosis (Thrombus) 05/2020 - 04/2019
2	Myocardial Infarction 05/2020 - 04/2019
2	Brain Ischemia (Cerebral Ischemia) 02/2019 - 08/2013
2	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 08/2018 - 06/2016
2	Hematoma 07/2018 - 11/2013
2	Deglutition Disorders (Dysphagia) 01/2017 - 05/2013
2	Heart Failure 02/2016 - 05/2013
2	Leukoaraiosis 11/2014 - 01/2014
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 10/2022
1	Glucose Intolerance 08/2022
1	Body Weight (Weight, Body) 01/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022
1	Coronary Disease (Coronary Heart Disease) 01/2022
1	Albuminuria 01/2022
1	Noncommunicable Diseases 08/2021
1	Postoperative Pain 01/2021
1	Cerebral Infarction 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2021

Drug/Important Bio-Agent (IBA)

31	Clopidogrel (Plavix)FDA Link 11/2022 - 06/2014
26	Glucose (Dextrose)FDA LinkGeneric 08/2022 - 09/2014
24	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2022 - 06/2014
12	Cytochrome P-450 CYP2C19IBA 11/2022 - 07/2016
12	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 01/2014
10	TicagrelorIBA 01/2022 - 01/2017
8	C-Reactive ProteinIBA 11/2022 - 01/2013
8	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2019
7	Indicators and Reagents (Reagents)IBA 11/2022 - 01/2014
7	Blood Glucose (Blood Sugar)IBA 01/2020 - 05/2013
6	Insulin (Novolin)FDA Link 01/2022 - 01/2018
6	danaparoid (Orgaran)FDA Link 01/2022 - 01/2016
6	Triglycerides (Triacylglycerol)IBA 01/2022 - 11/2015
6	Hemoglobins (Hemoglobin)IBA 11/2020 - 01/2016
4	oxidized low density lipoproteinIBA 11/2022 - 01/2021
4	LDL CholesterolIBA 11/2022 - 01/2021
4	AlbuminsIBA 01/2022 - 11/2017
3	Interleukin-6 (Interleukin 6)IBA 06/2022 - 01/2021
3	CholesterolIBA 01/2022 - 12/2020
3	Cystatin CIBA 01/2022 - 01/2021
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 11/2014
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2020 - 09/2014
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2022 - 01/2019
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 06/2022 - 02/2020
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 06/2022 - 02/2020
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022 - 01/2021
2	CreatinineIBA 01/2022 - 01/2022
2	LipidsIBA 01/2022 - 01/2019
2	Tenecteplase FDA Link 01/2022 - 01/2022
2	HomocysteineIBA 12/2021 - 07/2018
2	Lipoprotein(a)IBA 01/2021 - 12/2019
2	AnticoagulantsIBA 01/2021 - 01/2019
2	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 01/2021
2	Uric Acid (Urate)IBA 01/2021 - 02/2017
2	Nonesterified Fatty Acids (NEFA)IBA 01/2020 - 01/2020
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 10/2022
1	indobufenIBA 10/2022
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 06/2022
1	TransferasesIBA 02/2022
1	HDL CholesterolIBA 12/2021
1	Ropivacaine (Naropin)FDA LinkGeneric 01/2021
1	Choline (Choline Chloride)IBA 01/2021
1	Tirofiban (Aggrastat)FDA Link 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	Adenosine Diphosphate (ADP)IBA 01/2021
1	Phosphates (Orthophosphate)IBA 01/2021
1	CalciumIBA 01/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021
1	fibrin fragment D (D-dimer)IBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021

Therapy/Procedure

35	Therapeutics 11/2022 - 01/2013
14	Secondary Prevention 07/2022 - 06/2017
7	Thrombectomy 01/2021 - 06/2016
5	Stents 05/2020 - 08/2018
3	Length of Stay 01/2017 - 03/2014
2	Punctures 01/2021 - 01/2021
2	Glycemic Control 01/2019 - 01/2018
1	Local Anesthesia 01/2021
1	Conservative Treatment 01/2021